A Luisi

521 total citations
10 papers, 434 citations indexed

About

A Luisi is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, A Luisi has authored 10 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 8 papers in Cancer Research and 3 papers in Pathology and Forensic Medicine. Recurrent topics in A Luisi's work include Breast Cancer Treatment Studies (7 papers), HER2/EGFR in Cancer Research (4 papers) and Cancer-related Molecular Pathways (3 papers). A Luisi is often cited by papers focused on Breast Cancer Treatment Studies (7 papers), HER2/EGFR in Cancer Research (4 papers) and Cancer-related Molecular Pathways (3 papers). A Luisi collaborates with scholars based in Italy. A Luisi's co-authors include Rosella Silvestrini, Maria Grazia Daidone, Silvia Veneroni, Elvira Benini, Umberto Veronesi, B Salvadori, Monica Leutner, G. Di Fronzo, Patrizia Boracchi and Salvatore Andreola and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and British Journal of Cancer.

In The Last Decade

A Luisi

10 papers receiving 420 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Luisi Italy 8 285 256 144 109 72 10 434
J.C. Titley United Kingdom 9 249 0.9× 206 0.8× 111 0.8× 85 0.8× 85 1.2× 12 373
Balvinder Shoker United Kingdom 10 260 0.9× 218 0.9× 164 1.1× 126 1.2× 159 2.2× 18 482
F Khandan Germany 7 312 1.1× 295 1.2× 122 0.8× 88 0.8× 44 0.6× 10 449
Mervi Laakso Finland 5 279 1.0× 194 0.8× 196 1.4× 69 0.6× 156 2.2× 6 464
Sufeng Mao United States 4 216 0.8× 233 0.9× 159 1.1× 102 0.9× 75 1.0× 5 408
Ulrike Kronenwett Sweden 9 210 0.7× 291 1.1× 291 2.0× 62 0.6× 70 1.0× 9 514
D. Voduc Canada 3 307 1.1× 421 1.6× 182 1.3× 94 0.9× 105 1.5× 4 549
Beverly J. Lynch United States 7 236 0.8× 111 0.4× 172 1.2× 190 1.7× 66 0.9× 7 423
Jennie Jeong United States 6 174 0.6× 313 1.2× 230 1.6× 64 0.6× 75 1.0× 8 465
S. Oriana Italy 9 276 1.0× 138 0.5× 138 1.0× 83 0.8× 92 1.3× 18 422

Countries citing papers authored by A Luisi

Since Specialization
Citations

This map shows the geographic impact of A Luisi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Luisi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Luisi more than expected).

Fields of papers citing papers by A Luisi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Luisi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Luisi. The network helps show where A Luisi may publish in the future.

Co-authorship network of co-authors of A Luisi

This figure shows the co-authorship network connecting the top 25 collaborators of A Luisi. A scholar is included among the top collaborators of A Luisi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Luisi. A Luisi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Daidone, Maria Grazia, A Luisi, Gabriele Martelli, et al.. (2000). Biomarkers and outcome after tamoxifen treatment in node-positive breast cancers from elderly women. British Journal of Cancer. 82(2). 270–277. 32 indexed citations
2.
Silvestrini, Rosella, A Luisi, Milvia Zambetti, et al.. (2000). Cell proliferation and outcome following doxorubicin plus CMF regimens in node‐positive breast cancer. International Journal of Cancer. 87(3). 405–411. 16 indexed citations
3.
Daidone, Maria Grazia, A Luisi, Silvia Veneroni, Elvira Benini, & Rosella Silvestrini. (1999). Clinical studies of Bcl-2 and treatment benefit in breast cancer patients.. Endocrine Related Cancer. 6(1). 61–68. 68 indexed citations
4.
Silvestrini, Rosella, A Luisi, Maria Grazia Daidone, & Maria Gaetana Di Mauro. (1998). Effect of menstrual phase on cell proliferative rate of breast cancer. Breast Cancer Research and Treatment. 48(1). 93–94. 6 indexed citations
5.
Silvestrini, Rosella, et al.. (1997). Cell proliferation in 3,800 node-negative breast cancers: Concistency over time of biological and clinical information provided by3H-Thymidine labelling index. International Journal of Cancer. 74(1). 122–127. 48 indexed citations
6.
Silvestrini, Rosella, Silvia Veneroni, Elvira Benini, et al.. (1997). Expression of p53, Glutathione S -Transferase- , and Bcl-2 Proteins and Benefit From Adjuvant Radiotherapy in Breast Cancer. JNCI Journal of the National Cancer Institute. 89(9). 639–645. 88 indexed citations
7.
Daidone, Maria Grazia, Gabriele Martelli, Silvana Pilotti, et al.. (1995). Contribution of ploidy and cell kinetics from fine‐needle aspirates for the diagnosis of breast lesions: Study of 606 consecutive cases. Cytometry. 22(3). 177–180. 2 indexed citations
8.
Daidone, Maria Grazia, Rosella Silvestrini, A Luisi, et al.. (1995). Changes in biological markers after primary chemotherapy for breast cancers. International Journal of Cancer. 61(3). 301–305. 39 indexed citations
9.
Silvestrini, Rosella, Maria Grazia Daidone, A Luisi, et al.. (1995). Biologic and clinicopathologic factors as indicators of specific relapse types in node-negative breast cancer.. Journal of Clinical Oncology. 13(3). 697–704. 92 indexed citations
10.
Silvestrini, Rosella, Maria Grazia Daidone, G. Del Bino, et al.. (1993). Prognostic significance of proliferative activity and ploidy in node-negative breast cancers. Annals of Oncology. 4(3). 213–219. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J.C. Titley Breakdown of academic impact, for papers by Balvinder Shoker Breakdown of academic impact, for papers by F Khandan Breakdown of academic impact, for papers by Mervi Laakso Breakdown of academic impact, for papers by Sufeng Mao Breakdown of academic impact, for papers by Ulrike Kronenwett Breakdown of academic impact, for papers by D. Voduc Breakdown of academic impact, for papers by Beverly J. Lynch Breakdown of academic impact, for papers by Jennie Jeong Breakdown of academic impact, for papers by S. Oriana
Rankless by CCL
2026